192 related articles for article (PubMed ID: 10366511)
1. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
Barbato G; Cicero DO; Nardi MC; Steinkühler C; Cortese R; De Francesco R; Bazzo R
J Mol Biol; 1999 Jun; 289(2):371-84. PubMed ID: 10366511
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
5. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
Failla CM; Pizzi E; De Francesco R; Tramontano A
Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
[TBL] [Abstract][Full Text] [Related]
6. A zinc binding site in viral serine proteinases.
De Francesco R; Urbani A; Nardi MC; Tomei L; Steinkühler C; Tramontano A
Biochemistry; 1996 Oct; 35(41):13282-7. PubMed ID: 8873593
[TBL] [Abstract][Full Text] [Related]
7. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
[TBL] [Abstract][Full Text] [Related]
10. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
[TBL] [Abstract][Full Text] [Related]
11. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
[TBL] [Abstract][Full Text] [Related]
12. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
[TBL] [Abstract][Full Text] [Related]
14. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
Tautz N; Kaiser A; Thiel HJ
Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
16. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
Hamill P; Jean F
Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
[TBL] [Abstract][Full Text] [Related]
18. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S
Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325
[TBL] [Abstract][Full Text] [Related]
19. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease.
Yang SH; Lee CG; Song MK; Sung YC
Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335
[TBL] [Abstract][Full Text] [Related]
20. Product inhibition of the hepatitis C virus NS3 protease.
Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]